Pharmaceuticals

Improved OTC Access to Allergy Medications Driving Trends in the Autacoids And Related Drug Market

March 18, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Autacoids And Related Drug Market Evolve From 2026 To 2030?

The autacoids and related drug market size has experienced substantial expansion in recent years. This market is projected to grow from $52.81 billion in 2025 to $55.87 billion in 2026, with a compound annual growth rate (CAGR) of 5.8%. Historically, the market’s growth can be attributed to elements such as inflammatory disease prevalence, allergy incidence growth, cardiovascular disorder burden, gastrointestinal disorder treatments, and hospital pharmacology expansion.

The autacoids and related drug market is projected for significant expansion in the coming years. This market is anticipated to reach $70.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.8%. Factors contributing to this growth during the forecast period include the uptake of precision pharmacology, advancements in receptor-targeted drug development, the expansion of chronic disease management, the increase in outpatient treatment options, and the utilization of combination therapies. Key trends expected within this timeframe encompass the broadened application in inflammatory disease management, an intensified emphasis on receptor-specific drug mechanisms, an escalating need for targeted autacoid modulators, increased deployment in cardiovascular and respiratory care, and a higher acceptance of combination therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24159&type=smp

What Key Drivers Are Influencing The Growth Of The Autacoids And Related Drug Market?

The rising occurrence of cardiovascular diseases is projected to stimulate the expansion of the autacoids and related drugs market in the future. These disorders encompass conditions impacting the heart and blood vessels, such as coronary heart disease, heart failure, stroke, and hypertension. This increase in cardiovascular disease incidence is mainly linked to unhealthy dietary habits, given that excessive intake of saturated fats, trans fats, added sugars, and sodium leads to elevated blood pressure, obesity, and high cholesterol, all significant risk factors for cardiac ailments. Autacoids and associated medications improve cardiovascular well-being by regulating vascular tone and inflammatory responses, which are vital in conditions like hypertension and heart failure. Substances that target nitric oxide, endothelin, and prostacyclin pathways aid in re-establishing endothelial function, thus encouraging vasodilation and decreasing vascular resistance. As an illustration, in September 2023, data from the World Health Organization, an intergovernmental body based in Switzerland, indicated 17.9 million fatalities attributed to cardiovascular diseases. Consequently, the growing frequency of cardiovascular diseases is fueling the development of the autacoids and related drugs market.

Which Segment Areas Are Covered In The Autacoids And Related Drug Market Analysis?

The autacoids and related drug market covered in this report is segmented –

1) By Type: Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin

2) By Administration: Oral, Injectable, Topical, Intranasal, Inhalation

3) By Application: Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders

4) By End User: Hospitals, Clinics, Homecare, Pharmacies

Subsegments:

1) By Histamines: H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists

2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs

3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors

4) By Serotonin: 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators

5) By Bradykinin: Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

What Key Developments And Trends Are Impacting The Autacoids And Related Drug Market?

Major companies operating in autacoids and related drugs are prioritizing the development of innovative products, including antihistamines, with the aim of enhancing therapeutic efficacy, mitigating side effects, and more accurately and safely addressing emerging allergic and inflammatory conditions. Antihistamines are medications designed to block the effects of histamine, a chemical that your immune system releases during an allergic reaction. For instance, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceuticals company, launched Bilastine as an over-the-counter (OTC) medicine in Germany. This move represents a significant stride in improving access to effective allergy treatments. The 20 mg Bilastine tablets offer a non-sedating, second-generation antihistamine solution for individuals experiencing allergic symptoms such as hay fever and urticaria.

Which Global Companies Are Actively Competing In The Autacoids And Related Drug Market?

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy’s Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

Read the full autacoids and related drug market report here:

https://www.thebusinessresearchcompany.com/report/autacoids-and-related-drug-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Autacoids And Related Drug Market?

North America was the largest region in the autacoids and related drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Autacoids And Related Drug Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24159&type=smp

Browse Through More Reports Similar to the Global Autacoids And Related Drug Market 2026, By The Business Research Company

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Rheumatoid Arthritis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

Antacids Market Report 2026

https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795